{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:43:14Z","timestamp":1768837394094,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41390-025-03912-6","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:52:25Z","timestamp":1739177545000},"page":"1920-1928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased AGEs\/sRAGE ratio and dyslipidemia risk in Down syndrome youths: a cross-sectional study"],"prefix":"10.1038","volume":"98","author":[{"given":"Wendy P.","family":"Gast\u00e9lum Espinoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma M.","family":"Guadr\u00f3n Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenia K.","family":"Esparza Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas M.","family":"P\u00e9rez Villareal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica J.","family":"Picos C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loranda","family":"Calder\u00f3n Zamora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Vald\u00e9s Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto K.","family":"De la Herr\u00e1n Arita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Arias Gast\u00e9lum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-6997","authenticated-orcid":false,"given":"Javier A.","family":"Maga\u00f1a G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"3912_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis, S. E. et al. Down Syndrome. Nat. Rev. Dis. Prim. 6, 9\u20139 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"3912_CR2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMra1706537","volume":"382","author":"MJ Bull","year":"2020","unstructured":"Bull, M. J. Down Syndrome. N. Engl. J. Med. 382, 2344\u20132352 (2020).","journal-title":"N. Engl. J. Med."},{"key":"3912_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejmg.2016.06.005","volume":"59","author":"PS Buonuomo","year":"2016","unstructured":"Buonuomo, P. S. et al. Lipid profiles in a large cohort of Italian children with Down Syndrome. Eur. J. Med. Genet. 59, 392\u2013395 (2016).","journal-title":"Eur. J. Med. Genet."},{"key":"3912_CR4","doi-asserted-by":"crossref","unstructured":"Boato, E. et al. The use of virtual and computational technologies in the psychomotor and cognitive development of children with Down Syndrome: a systematic literature review. Int. J. Environ. Res. Public Health 19, 2955 (2022).","DOI":"10.3390\/ijerph19052955"},{"key":"3912_CR5","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2468-2667(23)00057-9","volume":"8","author":"RA Baksh","year":"2023","unstructured":"Baksh, R. A. et al. Multiple morbidity across the lifespan in people with Down Syndrome or intellectual disabilities: a population-based cohort study using electronic health records. Lancet Public Health 8, e453\u2013e462 (2023).","journal-title":"Lancet Public Health"},{"key":"3912_CR6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1540\/jsmr.57.94","volume":"57","author":"T Matsumoto","year":"2021","unstructured":"Matsumoto, T., Taguchi, K. & Kobayashi, T. Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function. J. Smooth Muscle Res. 57, 94\u2013107 (2021).","journal-title":"J. Smooth Muscle Res."},{"key":"3912_CR7","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.2337\/db16-0310","volume":"65","author":"PJ Saulnier","year":"2016","unstructured":"Saulnier, P. J. et al. Advanced glycation end products predict loss of renal function and correlate with lesions of diabetic kidney disease in American Indians with type 2 diabetes. Diabetes 65, 3744\u20133753 (2016).","journal-title":"Diabetes"},{"key":"3912_CR8","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7989180","volume":"2017","author":"A Guerin-Dubourg","year":"2017","unstructured":"Guerin-Dubourg, A. et al. Association between fluorescent advanced glycation end-products and vascular complications in type 2 diabetic patients. Biomed. Res Int 2017, 7989180 (2017).","journal-title":"Biomed. Res Int"},{"key":"3912_CR9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56242-z","volume":"9","author":"C Strieder-Barboza","year":"2019","unstructured":"Strieder-Barboza, C. et al. Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes. Sci. Rep. 9, 19748 (2019).","journal-title":"Sci. Rep."},{"key":"3912_CR10","doi-asserted-by":"crossref","unstructured":"de la Cruz-Ares, S. et al. Endothelial dysfunction and advanced glycation end products in patients with newly diagnosed versus established diabetes: from the cordioprev study. Nutrients 12, 238 (2020).","DOI":"10.3390\/nu12010238"},{"key":"3912_CR11","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3390\/ijerph18147236","volume":"18","author":"J Salazar","year":"2021","unstructured":"Salazar, J. et al. Advanced glycation end products: new clinical and molecular perspectives. Int J. Environ. Res. Public Health 18, 7236 (2021).","journal-title":"Int J. Environ. Res. Public Health"},{"key":"3912_CR12","doi-asserted-by":"crossref","unstructured":"Kim, Y. Blood and tissue advanced glycation end products as determinants of cardiometabolic disorders focusing on human studies. Nutrients 15, 2002 (2023).","DOI":"10.3390\/nu15082002"},{"key":"3912_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2018.06.005","volume":"47","author":"K Nowotny","year":"2018","unstructured":"Nowotny, K., Schr\u00f6ter, D., Schreiner, M. & Grune, T. Dietary advanced glycation end products and their relevance for human health. Ageing Res. Rev. 47, 55\u201366 (2018).","journal-title":"Ageing Res. Rev."},{"key":"3912_CR14","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/nu13103370","volume":"13","author":"K Litwinowicz","year":"2021","unstructured":"Litwinowicz, K., Waszczuk, E. & Gamian, A. Advanced glycation end-products in common non-infectious liver diseases: systematic review and meta-analysis. Nutrients 13, 3370 (2021).","journal-title":"Nutrients"},{"key":"3912_CR15","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G. & Adem, A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules 12, 542 (2022).","DOI":"10.3390\/biom12040542"},{"key":"3912_CR16","doi-asserted-by":"crossref","first-page":"3818196","DOI":"10.1155\/2020\/3818196","volume":"2020","author":"A Perrone","year":"2020","unstructured":"Perrone, A., Giovino, A., Benny, J. & Martinelli, F. Advanced glycation end products (AGEs): biochemistry, signaling, analytical methods, and epigenetic effects. Oxid. Med Cell Longev. 2020, 3818196\u20133818196 (2020).","journal-title":"Oxid. Med Cell Longev."},{"key":"3912_CR17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin, A., Beckman, J. A., Schmidt, A. M. & Creager, M. A. Advanced glycation end products. Circulation 114, 597\u2013605 (2006).","journal-title":"Circulation"},{"key":"3912_CR18","doi-asserted-by":"crossref","unstructured":"Zgutka, K., Tkacz, M., Tomasiak, P. & Tarnowski, M. A role for advanced glycation end products in molecular ageing. Int. J. Mol. Sci. 24, 9881 (2023).","DOI":"10.3390\/ijms24129881"},{"key":"3912_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.bbadis.2011.03.013","volume":"1812","author":"C Campos","year":"2011","unstructured":"Campos, C., Guzm\u00e1n, R., L\u00f3pez-Fern\u00e1ndez, E. & Casado, \u00c1. Evaluation of urinary biomarkers of oxidative\/nitrosative stress in adolescents and adults with Down Syndrome. Biochim. Biophys. Acta Mol. Basis Dis. 1812, 760\u2013768 (2011).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"3912_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.06.011","volume":"72","author":"AM Schmidt","year":"2015","unstructured":"Schmidt, A. M. Soluble rages\u2014prospects for treating & tracking metabolic and inflammatory disease. Vasc. Pharm. 72, 1\u20138 (2015).","journal-title":"Vasc. Pharm."},{"key":"3912_CR21","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","volume":"22","author":"A Raucci","year":"2008","unstructured":"Raucci, A. et al. A soluble form of the receptor for advanced glycation endproducts (rage) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (Adam10). Faseb J. 22, 3716\u20133727 (2008).","journal-title":"Faseb J."},{"key":"3912_CR22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1096\/fj.07-9909com","volume":"22","author":"BI Hudson","year":"2008","unstructured":"Hudson, B. I. et al. Identification, classification, and expression of rage gene splice variants. Faseb J. 22, 1572\u20131580 (2008).","journal-title":"Faseb J."},{"key":"3912_CR23","volume":"2018","author":"G Yang","year":"2018","unstructured":"Yang, G. et al. Endogenous secretory receptor for advanced glycation end products protects endothelial cells from AGEs induced apoptosis. Biomed. Res Int 2018, 8216578 (2018).","journal-title":"Biomed. Res Int"},{"key":"3912_CR24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fendo.2019.00426","volume":"10","author":"D Corica","year":"2019","unstructured":"Corica, D. et al. Could age\/rage-related oxidative homeostasis dysregulation enhance susceptibility to pathogenesis of cardio-metabolic complications in childhood obesity? Front. Endocrinol. 10, 426 (2019).","journal-title":"Front. Endocrinol."},{"key":"3912_CR25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40618-020-01231-7","volume":"43","author":"RM Ruggeri","year":"2020","unstructured":"Ruggeri, R. M. et al. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto\u2019s thyroiditis. J. Endocrinol. Investig. 43, 1337\u20131342 (2020).","journal-title":"J. Endocrinol. Investig."},{"key":"3912_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2023.02.005","volume":"376","author":"G Tsirebolos","year":"2023","unstructured":"Tsirebolos, G. et al. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease. Int J. Cardiol. 376, 127\u2013133 (2023).","journal-title":"Int J. Cardiol."},{"key":"3912_CR27","first-page":"1","volume":"11","author":"RJ Kuczmarski","year":"2002","unstructured":"Kuczmarski, R. J. et al. 2000 Cdc growth charts for the United States: methods and development. Vital. Health Stat. 11, 1\u2013190 (2002).","journal-title":"Vital. Health Stat."},{"key":"3912_CR28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/ajmg.a.62637","volume":"188","author":"KA Flores Arizmendi","year":"2022","unstructured":"Flores Arizmendi, K. A. et al. Growth charts for Mexican children with Down Syndrome. Am. J. Med. Genet. A 188, 1170\u20131183 (2022).","journal-title":"Am. J. Med. Genet. A"},{"key":"3912_CR29","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents.","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128, S213 (2011).","journal-title":"Pediatrics"},{"key":"3912_CR30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.33549\/physiolres.932895","volume":"63","author":"M Vrabl\u00edk","year":"2014","unstructured":"Vrabl\u00edk, M., Dobiasova, M., Zlatohl\u00e1vek, L., Urbanov\u00e1, Z. & Ceska, R. Biomarkers of cardiometabolic risk in obese\/overweight children: effect of lifestyle intervention. Physiol. Res. 63, 743 (2014).","journal-title":"Physiol. Res."},{"key":"3912_CR31","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2337\/dci18-0052","volume":"41","author":"S Arslanian","year":"2018","unstructured":"Arslanian, S. et al. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American diabetes association. Diab. Care 41, 2648\u20132668 (2018).","journal-title":"Diab. Care"},{"key":"3912_CR32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1006\/bbrc.1998.8186","volume":"243","author":"P Odetti","year":"1998","unstructured":"Odetti, P. et al. Early glycoxidation damage in brains from Down\u2019s Syndrome. Biochem. Biophys. Res. Commun. 243, 849\u2013851 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3912_CR33","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mehy.2004.08.020","volume":"64","author":"R Thiel","year":"2005","unstructured":"Thiel, R. & Fowkes, S. Can cognitive deterioration associated with Down Syndrome be reduced? Med. Hypotheses 64, 524\u2013532 (2005).","journal-title":"Med. Hypotheses"},{"key":"3912_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10408363.2020.1791045","volume":"58","author":"M Steenbeke","year":"2021","unstructured":"Steenbeke, M. et al. The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome. Crit. Rev. Clin. Lab Sci. 58, 113\u2013130 (2021).","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"3912_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10522-006-9002-5","volume":"7","author":"FV Pallard\u00f3","year":"2006","unstructured":"Pallard\u00f3, F. V. et al. Multiple evidence for an early age pro-oxidant state in Down Syndrome patients. Biogerontology 7, 211\u2013220 (2006).","journal-title":"Biogerontology"},{"key":"3912_CR36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.lfs.2011.08.006","volume":"89","author":"C Campos","year":"2011","unstructured":"Campos, C., Guzm\u00e1n, R., L\u00f3pez-Fern\u00e1ndez, E. & Casado, \u00c1. Evaluation of urinary biomarkers of oxidative\/nitrosative stress in children with Down Syndrome. Life Sci. 89, 655\u2013661 (2011).","journal-title":"Life Sci."},{"key":"3912_CR37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmhg.2012.08.008","volume":"14","author":"IE Abdel-Meguid","year":"2013","unstructured":"Abdel-Meguid, I. E., Abdel-Salam, E., Latif, D. M. A., Korraa, S. & Ismaiel, A. Markers of neural degeneration and regeneration in Down Syndrome patients. Egypt J. Med. Hum. Genet. 14, 49\u201353 (2013).","journal-title":"Egypt J. Med. Hum. Genet."},{"key":"3912_CR38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000354831","volume":"80","author":"S Accacha","year":"2013","unstructured":"Accacha, S. et al. Plasma advanced glycation end products (AGEs), receptors for AGEs and their correlation with inflammatory markers in middle school-age children. Horm. Res. Paediatr. 80, 318\u2013327 (2013).","journal-title":"Horm. Res. Paediatr."},{"key":"3912_CR39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.20452\/pamw.1821","volume":"123","author":"E Grzebyk","year":"2013","unstructured":"Grzebyk, E., Knapik-Kordecka, M. & Piwowar, A. Advanced glycation end-products and cathepsin cysteine protease in type 2 diabetic patients. Pol. Arch. Intern Med. 123, 364\u2013370 (2013).","journal-title":"Pol. Arch. Intern Med."},{"key":"3912_CR40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.33549\/physiolres.930234","volume":"51","author":"M Kalousov\u00e1","year":"2002","unstructured":"Kalousov\u00e1, M., Skrha, J. & Zima, T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res 51, 597\u2013604 (2002).","journal-title":"Physiol. Res"},{"key":"3912_CR41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.metabol.2018.01.023","volume":"83","author":"SA Palma-Duran","year":"2018","unstructured":"Palma-Duran, S. A. et al. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for ages (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults. Metabolism 83, 120\u2013127 (2018).","journal-title":"Metabolism"},{"key":"3912_CR42","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/advances\/nmab072","volume":"12","author":"E Sharifi-Zahabi","year":"2021","unstructured":"Sharifi-Zahabi, E., Sharafabad, F. H., Abdollahzad, H., Malekahmadi, M. & Rad, N. B. Circulating advanced glycation end products and their soluble receptors in relation to all-cause and cardiovascular mortality: a systematic review and meta-analysis of prospective observational studies. Adv. Nutr. 12, 2157\u20132171 (2021).","journal-title":"Adv. Nutr."},{"key":"3912_CR43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10719-016-9696-9","volume":"33","author":"R Gureck\u00e1","year":"2016","unstructured":"Gureck\u00e1, R., Koborov\u00e1, I., Csongov\u00e1, M., \u0160ebek, J. & \u0160ebekov\u00e1, K. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1\/semicarbazide-sensitive amine oxidase (Svap-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study. Glycoconj. J. 33, 599\u2013606 (2016).","journal-title":"Glycoconj. J."},{"key":"3912_CR44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000501718","volume":"92","author":"R Rodr\u00edguez-Mortera","year":"2019","unstructured":"Rodr\u00edguez-Mortera, R. et al. Soluble receptor for advanced glycation end products and its correlation with vascular damage in adolescents with obesity. Horm. Res Paediatr. 92, 28\u201335 (2019).","journal-title":"Horm. Res Paediatr."},{"key":"3912_CR45","doi-asserted-by":"crossref","unstructured":"Vekic, J. et al. The role of advanced glycation end products on dyslipidemia. Metabolites 13, 77 (2023).","DOI":"10.3390\/metabo13010077"},{"key":"3912_CR46","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/ijms23031766","volume":"23","author":"M Snelson","year":"2022","unstructured":"Snelson, M., Lucut, E. & Coughlan, M. T. The role of age-rage signalling as a modulator of gut permeability in diabetes. Int. J. Mol. Sci. 23, 1766 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"3912_CR47","doi-asserted-by":"crossref","unstructured":"Molinari, P. et al. AGEs and sRAGE variations at different timepoints in patients with chronic kidney disease. Antioxidants 10, 1994 (2021).","DOI":"10.3390\/antiox10121994"},{"key":"3912_CR48","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0035-1570754","volume":"25","author":"E McNair","year":"2016","unstructured":"McNair, E., Qureshi, M., Prasad, K. & Pearce, C. Atherosclerosis and the hypercholesterolemic age-rage axis. Int. J. Angiol. 25, 110\u2013116 (2016).","journal-title":"Int. J. Angiol."},{"key":"3912_CR49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.59566\/IJBS.2011.7191","volume":"7","author":"MN Amin","year":"2011","unstructured":"Amin, M. N., Mosa, A. A. & El-Shishtawy, M. M. Clinical study of advanced glycation end products in Egyptian diabetic obese and non-obese patients. Int. J. Biomed. Sci. 7, 191\u2013200 (2011).","journal-title":"Int. J. Biomed. Sci."},{"key":"3912_CR50","volume":"4","author":"XH Li","year":"2013","unstructured":"Li, X. H. et al. Glycation exacerbates the neuronal toxicity of \u0392-amyloid. Cell Death Dis. 4, e673 (2013).","journal-title":"Cell Death Dis."},{"key":"3912_CR51","doi-asserted-by":"crossref","first-page":"e2033012","DOI":"10.1001\/jamanetworkopen.2020.33012","volume":"4","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Assessment of advanced glycation end products and receptors and the risk of dementia. JAMA Netw. Open 4, e2033012 (2021).","journal-title":"JAMA Netw. Open"},{"key":"3912_CR52","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1017\/S1041610217000886","volume":"29","author":"H Drenth","year":"2017","unstructured":"Drenth, H. et al. Association between advanced glycation end-products and functional performance in Alzheimer\u2019s disease and mixed dementia. Int Psychogeriatr. 29, 1525\u20131534 (2017).","journal-title":"Int Psychogeriatr."},{"key":"3912_CR53","volume":"13","author":"RA Taylor","year":"2023","unstructured":"Taylor, R. A. et al. Dementia risk analysis using temporal event modeling on a large real-world dataset. Sci. Rep. 13, 22618 (2023).","journal-title":"Sci. Rep."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03912-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03912-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03912-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:03:58Z","timestamp":1762880638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03912-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3912"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-03912-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained in writing from each participant\u2019s parent or guardian, and all participant information was anonymized to ensure confidentiality. The study was approved by the Research Ethics Committee of the Faculty of Medicine at the Autonomous University of Sinaloa with registration number CONBIO\u00c9TICA-25-CEI-003-20181012, and conducted following the bioethical principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}